Vasorelaxant and antioxidant activity of the isoflavone metabolite equol in carotid and cerebral arteries

Brain Research

Volumn 1141, Issue 1, 2007, Pages 99-107

  Jackman, Katherine A ^a   Woodman, Owen L ^a   Chrissobolis, Sophocles ^a   Sobey, Christopher G ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Antioxidant; Cerebral; Isoflavone; Phytoestrogen; Vascular; Vasodilatation

Indexed keywords

ANGIOTENSIN II; DAIDZEIN; EQUOL; ISOFLAVONE DERIVATIVE; NITRIC OXIDE SYNTHASE; POTASSIUM; POTASSIUM CHANNEL; SUPEROXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTERY ENDOTHELIUM; ARTICLE; BASILAR ARTERY; BLOOD PRESSURE; BRAIN ARTERY; CAROTID ARTERY; CELL LEVEL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; HYPERTENSION; IN VIVO STUDY; ISOLATED ARTERY; MALE; NONHUMAN; POTASSIUM CELL LEVEL; PRIORITY JOURNAL; RAT; VASODILATATION;

ANALYSIS OF VARIANCE; ANGIOTENSIN II; ANIMALS; ANTIOXIDANTS; BLOOD PRESSURE; CAROTID ARTERIES; CEREBRAL ARTERIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENZYME INHIBITORS; FEMALE; HYPERTENSION; ISOFLAVONES; MALE; PHYTOESTROGENS; RATS; SUPEROXIDES; VASODILATION;

RATTUS;

EID: 33847689036     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.01.007     Document Type: Article

References (46)

1. Ajay M., Gilani A.U., and Mustafa M.R. Effects of flavonoids on vascular smooth muscle of the isolated rat thoracic aorta. Life Sci. 74 (2003) 603-612
2. Arora A., Nair M.G., and Strasburg G.M. Antioxidant activities of isoflavones and their biological metabolites in a liposomal system. Arch. Biochem. Biophys. 356 (1998) 133-141
3. Atkinson C., Berman S., Humbert O., and Lampe J.W. In vitro incubation of human feces with daidzein and antibiotics suggests interindividual differences in the bacteria responsible for equol production. J. Nutr. 134 (2004) 596-599
4. Atkinson C., Frankenfeld C.L., and Lampe J.W. Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health. Exp. Biol. Med. (Maywood) 230 (2005) 155-170
5. Blair R.M., Appt S.E., Bennetau-Pelissero C., Clarkson T.B., Anthony M.S., Lamothe V., and Potter S.M. Dietary soy and soy isoflavones have gender-specific effects on plasma lipids and isoflavones in golden Syrian f(1)b hybrid hamsters. J. Nutr. 132 (2002) 3585-3591
6. Blair R.M., Appt S.E., Franke A.A., and Clarkson T.B. Treatment with antibiotics reduces plasma equol concentration in cynomolgus monkeys (Macaca fascicularis). J. Nutr. 133 (2003) 2262-2267
7. Chin-Dusting J.P., Fisher L.J., Lewis T.V., Piekarska A., Nestel P.J., and Husband A. The vascular activity of some isoflavone metabolites: implications for a cardioprotective role. Br. J. Pharmacol. 133 (2001) 595-605
8. Chin-Dusting J.P., Boak L., Husband A., and Nestel P.J. The isoflavone metabolite dehydroequol produces vasodilatation in human resistance arteries via a nitric oxide-dependent mechanism. Atherosclerosis 176 (2004) 45-48
9. Faraci F.M., and Heistad D.D. Regulation of large cerebral arteries and cerebral microvascular pressure. Circ. Res. 66 (1990) 8-17
10. Figtree G.A., Griffiths H., Lu Y.Q., Webb C.M., MacLeod K., and Collins P. Plant-derived estrogens relax coronary arteries in vitro by a calcium antagonistic mechanism. J. Am. Coll. Cardiol. 35 (2000) 1977-1985
11. Gimenez I., Lou M., Vargas F., Alvarez-Guerra M., Mayoral J.A., Martinez R.M., Garay R.P., and Alda J.O. Renal and vascular actions of equol in the rat. J. Hypertens. 15 (1997) 1303-1308
12. Hedlund T.E., Johannes W.U., and Miller G.J. Soy isoflavonoid equol modulates the growth of benign and malignant prostatic epithelial cells in vitro. Prostate 54 (2003) 68-78
13. Hwang J., Sevanian A., Hodis H.N., and Ursini F. Synergistic inhibition of LDL oxidation by phytoestrogens and ascorbic acid. Free Radical Biol. Med. 29 (2000) 79-89
14. Ingham J.L. Naturally occurring isoflavonoids (1855-1981). Fortsch Org. Nat. 43 (1983) 1-265
15. Karr S.C., Lampe J.W., Hutchins A.M., and Slavin J.L. Urinary isoflavonoid excretion in humans is dose dependent at low to moderate levels of soy-protein consumption. Am. J. Clin. Nutr. 66 (1997) 46-51
16. Kelly G.E., Joannou G.E., Reeder A.Y., Nelson C., and Waring M.A. The variable metabolic response to dietary isoflavones in humans. Proc. Soc. Exp. Biol. Med. 208 (1995) 40-43
17. Kreijkamp-Kaspers S., Kok L., Bots M.L., Grobbee D.E., Lampe J.W., and van der Schouw Y.T. Randomized controlled trial of the effects of soy protein containing isoflavones on vascular function in postmenopausal women. Am. J. Clin. Nutr. 81 (2005) 189-195
18. Lamartiniere C.A., Wang J., Smith-Johnson M., and Eltoum I.E. Daidzein: bioavailability, potential for reproductive toxicity, and breast cancer chemoprevention in female rats. Toxicol. Sci. 65 (2002) 228-238
19. Lampe J.W., Karr S.C., Hutchins A.M., and Slavin J.L. Urinary equol excretion with a soy challenge: influence of habitual diet. Proc. Soc. Exp. Biol. Med. 217 (1998) 335-339
20. Liew R., Williams J.K., Collins P., and MacLeod K.T. Soy-derived isoflavones exert opposing actions on Guinea pig ventricular myocytes. J. Pharmacol. Exp. Ther. 304 (2003) 985-993
21. Low Dog T. Menopause: a review of botanical dietary supplements. Am. J. Med. 118 (2005) 98-108
22. Mahn K., Borras C., Knock G.A., Taylor P., Khan I.Y., Sugden D., Poston L., Ward J.P., Sharpe R.M., Vina J., Aaronson P.I., and Mann G.E. Dietary soy isoflavone induced increases in antioxidant and eNOS gene expression lead to improved endothelial function and reduced blood pressure in vivo. FASEB J. 19 (2005) 1755-1757
23. Martin D.S., Breitkopf N.P., Eyster K.M., and Williams J.L. Dietary soy exerts an antihypertensive effect in spontaneously hypertensive female rats. Am. J. Physiol.: Regul., Integr. Comp. Physiol. 281 (2001) R553-R560
24. Martin D.S., Williams J.L., Breitkopf N.P., and Eyster K.M. Pressor responsiveness to angiotensin in soy-fed spontaneously hypertensive rats. Can. J. Physiol. Pharmacol. 80 (2002) 1180-1186
25. Meyer B.J., Larkin T.A., Owen A.J., Astheimer L.B., Tapsell L.C., and Howe P.R. Limited lipid-lowering effects of regular consumption of whole soybean foods. Ann. Nutr. Metab. 48 (2004) 67-78
26. Miller A.A., Drummond G.R., Schmidt H.H., and Sobey C.G. NADPH oxidase activity and function are profoundly greater in cerebral versus systemic arteries. Circ. Res. 97 (2005) 1055-1062
27. Mishra S.K., Abbot S.E., Choudhury Z., Cheng M., Khatab N., Maycock N.J., Zavery A., and Aaronson P.I. Endothelium-dependent relaxation of rat aorta and main pulmonary artery by the phytoestrogens genistein and daidzein. Cardiovasc. Res. 46 (2000) 539-546
28. Mitchell J.H., Gardner P.T., McPhail D.B., Morrice P.C., Collins A.R., and Duthie G.G. Antioxidant efficacy of phytoestrogens in chemical and biological model systems. Arch. Biochem. Biophys. 360 (1998) 142-148
29. Nevala R., Korpela R., and Vapaatalo H. Plant derived estrogens relax rat mesenteric artery in vitro. Life Sci. 63: (1998) PL95-PL100
30. Nevala R., Vaskonen T., Vehniainen J., Korpela R., and Vapaatalo H. Soy based diet attenuates the development of hypertension when compared to casein based diet in spontaneously hypertensive rat. Life Sci. 66 (2000) 115-124
31. Ohta A., Uehara M., Sakai K., Takasaki M., Adlercreutz H., Morohashi T., and Ishimi Y. A combination of dietary fructooligosaccharides and isoflavone conjugates increases femoral bone mineral density and equol production in ovariectomized mice. J. Nutr. 132 (2002) 2048-2054
32. Paravicini T.M., Gulluyan L.M., Dusting G.J., and Drummond G.R. Increased NADPH oxidase activity, gp91phox expression, and endothelium-dependent vasorelaxation during neointima formation in rabbits. Circ. Res. 91 (2002) 54-61
33. Park E., Shin J.I., Park O.J., and Kang M.H. Soy isoflavone supplementation alleviates oxidative stress and improves systolic blood pressure in male spontaneously hypertensive rats. J. Nutr. Sci. Vitaminol. (Tokyo) 51 (2005) 254-259
34. Rimbach G., De Pascual-Teresa S., Ewins B.A., Matsugo S., Uchida Y., Minihane A.M., Turner R., VafeiAdou K., and Weinberg P.D. Antioxidant and free radical scavenging activity of isoflavone metabolites. Xenobiotica 33 (2003) 913-925
35. Rowland I., Wiseman H., Sanders T., Adlercreutz H., and Bowey E. Metabolism of oestrogens and phytoestrogens: role of the gut microflora. Biochem. Soc. Trans. 27 (1999) 304-308
36. Rufer C.E., and Kulling S.E. Antioxidant activity of isoflavones and their major metabolites using different in vitro assays. J. Agric. Food Chem. 54 (2006) 2926-2931
37. Rufer C.E., Glatt H., and Kulling S.E. Structural elucidation of hydroxylated metabolites of the isoflavan equol by gas chromatography-mass spectrometry and high-performance liquid chromatography-mass spectrometry. Drug Metab. Dispos. 34 (2006) 51-60
38. Sacks F.M., Lichtenstein A., VanHorn L., Harris W., Kris-Etherton P., and Winston M. Soy protein, isoflavones, and cardiovascular health. An American Heart Association Science Advisory for Professionals From the Nutrition Committee. Circulation (2006)
39. 2+ entry inhibition. J. Cereb. Blood Flow Metab. 21 (2001) 422-429
40. Schreihofer D.A., Do K.D., and Schreihofer A.M. High-soy diet decreases infarct size after permanent middle cerebral artery occlusion in female rats. Am. J. Physiol.: Regul., Integr. Comp. Physiol. 289 (2005) R103-R108
41. Setchell K.D., Borriello S.P., Hulme P., Kirk D.N., and Axelson M. Nonsteroidal estrogens of dietary origin: possible roles in hormone-dependent disease. Am. J. Clin. Nutr. 40 (1984) 569-578
42. Setchell K.D., Brown N.M., and Lydeking-Olsen E. The clinical importance of the metabolite equol-A clue to the effectiveness of soy and its isoflavones. J. Nutr. 132 (2002) 3577-3584
43. Setchell K.D., Clerici C., Lephart E.D., Cole S.J., Heenan C., Castellani D., Wolfe B.E., Nechemias-Zimmer L., Brown N.M., Lund T.D., Handa R.J., and Heubi J.E. S-equol, a potent ligand for estrogen receptor beta, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora. Am. J. Clin. Nutr. 81 (2005) 1072-1079
44. Sobey C.G., and Quan L. Impaired cerebral vasodilator responses to NO and PDE V inhibition after subarachnoid hemorrhage. Am. J. Physiol. 277 (1999) H1718-H1724
45. Torregrosa G., Burguete M.C., Perez-Asensio F.J., Salom J.B., Gil J.V., and Alborch E. Pharmacological profile of phytoestrogens in cerebral vessels: in vitro study with rabbit basilar artery. Eur. J. Pharmacol. 482 (2003) 227-234
46. Turner R., Baron T., Wolffram S., Minihane A.M., Cassidy A., Rimbach G., and Weinberg P.D. Effect of circulating forms of soy isoflavones on the oxidation of low density lipoprotein. Free Radical Res. 38 (2004) 209-216